Does Diluting Etomidate Vape Oil with Glycerin Constitute Drug Manufacturing in Taiwan? Taichung Court Case and Legal Analysis
商品圖像
-
商品資訊
Table of contents
- 1. Why the Taichung Court Classified the Conduct as Drug Manufacturing
- 2. Supreme Court Standards for Mixing, Processing, and Repackaging Drugs
- 3. Etomidate's Classification Change: Category 2 to Category 1
- 4. Why a Serious Drug Manufacturing Offense Resulted in a 32-Month Sentence
- 5. Criminal Defense Strategies in Etomidate Manufacturing Cases
- 6. Can a Two-Year-and-Eight-Month Sentence Be Converted into a Fine?
- 7. What This Judgment Means for Future Drug Cases
- 8. Legal Assistance from Chien Sheng International Law Firm
- 9. Frequently Asked Questions About Etomidate Drug Manufacturing in Taiwan
A recent drug case in Taichung, Taiwan, has raised an important legal question: Can mixing glycerin with existing etomidate vape oil constitute illegal drug manufacturing, even when no new controlled substance is chemically synthesized?
According to media reports, a man surnamed Lee was found with three electronic cigarette cartridges containing etomidate, commonly associated with so-called zombie vapes. He admitted filling empty cartridges with etomidate vape oil and glycerin but argued that the original liquid was already usable. He claimed the glycerin was added only to reduce the harsh sensation and excessive effects of inhalation, and that the cartridges were intended for personal use rather than sale.
The Taichung District Court rejected the argument that his conduct amounted merely to repackaging. It concluded that diluting the substance and improving its usability constituted processing that could fall within the legal definition of drug manufacturing.
➡︎ The defendant was sentenced to two years and eight months in prison for manufacturing a Category 2 narcotic. The court applied statutory sentence reductions after considering his admissions, the limited quantity involved, and the absence of evidence that the cartridges had entered the market. The judgment was reported as appealable.
➡︎ The significance of this case extends beyond etomidate. It illustrates how Taiwanese courts distinguish simple drug possession or repackaging from processing that changes a controlled substance's characteristics or method of administration.
1. Why the Taichung Court Classified the Conduct as Drug Manufacturing
1. The Defendant's Explanation
The defendant maintained that the etomidate vape oil was already a finished product and could be used without additional processing.
➠ He stated that he had merely transferred the liquid into empty cartridges and added glycerin to reduce its harshness. He did not claim to have synthesized etomidate or added another narcotic ingredient.
➠ His principal argument was that changing the container and diluting an existing substance should not automatically constitute manufacturing a narcotic.
2. Why the Court Rejected the Repackaging Argument
The court placed particular weight on the defendant's explanation of why glycerin had been added.According to the reported judgment, the original etomidate liquid produced an excessively harsh and intense experience. The defendant added glycerin to dilute its effects and make inhalation easier to tolerate.
The court considered that the process altered the substance's practical characteristics and facilitated its use.
➠ It therefore characterized the conduct as a form of drug processing or optimization rather than mere possession or packaging.
The central issue was not whether a chemical synthesis reaction occurred. Instead, the court examined whether the processing changed the drug's effects, usability, or method of administration in a legally significant way.
2. Supreme Court Standards for Mixing, Processing, and Repackaging Drugs
1. Drug Manufacturing Is Not Limited to Chemical Synthesis
In Supreme Court Criminal Judgment No. 521 of 2021 (110 Tai-Shang No. 521), the Court addressed the scope of drug manufacturing under Article 4 of Taiwan's Narcotics Hazard Prevention Act.
The concept of manufacturing is not necessarily limited to synthesizing a controlled substance from chemical precursors or extracting an active ingredient.
Depending on the circumstances, unlawful processing, mixing, refining, or preparation that changes a drug's properties, effects, or manner of use may also constitute manufacturing.Physical processing can therefore raise criminal liability even when the underlying controlled substance already exists.
2. Simple Packaging Does Not Automatically Constitute Manufacturing
The Supreme Court's approach does not mean every act of dividing, mixing, sealing, or packaging drugs is manufacturing.
Conduct involving an already finished substance may require a different legal assessment where the defendant merely changes its container, applies labels, divides it into portions, or prepares it for personal use without materially altering its effects or method of administration.
Courts must evaluate the overall process, the purpose of the conduct, and the resulting characteristics of the substance.The distinction is particularly important because drug manufacturing carries substantially heavier penalties than ordinary possession.
3. When Processing May Cross the Legal Boundary
The legal risk increases where additional processing is found to change how a controlled substance can be administered or experienced.
In the Taichung case, the court focused on the defendant's stated purpose of reducing harshness and making the etomidate liquid easier to inhale.
The resulting legal question was whether the conduct merely diluted an existing product or transformed its practical usability sufficiently to qualify as manufacturing.That distinction must be determined from the evidence in each case, not from the presence of glycerin alone.
3. Etomidate's Classification Change: Category 2 to Category 1
1. Etomidate Was a Category 2 Narcotic When the Conduct Occurred
Taiwan's Executive Yuan reclassified etomidate from a Category 3 narcotic to a Category 2 narcotic on November 27, 2024.The alleged conduct in this case occurred on October 8, 2025.
At that time, etomidate was therefore classified as a Category 2 narcotic under Taiwan's Narcotics Hazard Prevention Act.
Under Article 4, manufacturing, transporting, or selling Category 2 narcotics carries a statutory penalty of life imprisonment or imprisonment of at least ten years, with a possible additional fine of up to NT$15 million.
2. Etomidate Became a Category 1 Narcotic in June 2026
On June 25, 2026, the Executive Yuan announced the reclassification of etomidate and several related substances from Category 2 to Category 1 narcotics, effective June 27, 2026.
Under Article 4, manufacturing, transporting, or selling Category 1 narcotics carries a statutory penalty of death or life imprisonment, with a possible additional fine of up to NT$30 million.
➠ This reclassification substantially increased the potential criminal consequences for conduct occurring after the new classification took effect.
3. Can the New Category 1 Penalties Apply to Earlier Conduct?
The more severe classification cannot simply be applied retroactively to conduct that occurred while etomidate was classified as a Category 2 narcotic.
Under Article 2 of Taiwan's Criminal Code, where the law changes after an act, the law in force at the time of the act generally applies, unless the subsequent law is more favorable to the defendant.
Because the defendant's alleged conduct occurred in October 2025, the later reclassification does not automatically justify imposing the heavier Category 1 manufacturing penalties.
This reflects the principles of legality and protection against unfavorable retroactive criminal punishment.
4. Why a Serious Drug Manufacturing Offense Resulted in a 32-Month Sentence
1. The Original Statutory Penalty Remained Severe
A sentence of two years and eight months does not mean that manufacturing Category 2 narcotics ordinarily carries such a low statutory penalty.
➠ The underlying offense remains punishable by life imprisonment or imprisonment of at least ten years.
➠ The reported sentence resulted from the court's application of sentence-reduction provisions after finding that the manufacturing offense had been established.
2. Sentence Reduction for Confession Under Article 17
Article 17, Paragraph 2 of the Narcotics Hazard Prevention Act provides for sentence reduction when the defendant satisfies the statutory confession requirements during investigation and successive court proceedings.
According to the news report, the court interpreted the defendant's detailed admissions concerning his conduct and the relevant facts as sufficient to support this reduction.
However, acknowledging isolated facts during one interview does not automatically satisfy the legal requirements.The substance and timing of the defendant's statements must be examined throughout the proceedings.
3. Discretionary Mitigation Under Criminal Code Article 59
Article 59 of Taiwan's Criminal Code permits discretionary sentence reduction where the circumstances of an offense are clearly deserving of compassion and imposing the statutory minimum would be excessively harsh.
In this case, the court reportedly considered that only three cartridges were produced, they were intended primarily for personal use, and they had not entered the market.
➠ These circumstances supported a further reduction.Nevertheless, a small quantity or personal-use purpose does not automatically require Article 59 mitigation.The court must evaluate the offense as a whole and explain why the circumstances justify exceptional leniency.
5. Criminal Defense Strategies in Etomidate Manufacturing Cases
1. Argue That the Conduct Was Repackaging Rather Than Manufacturing
A defense may begin by examining whether the controlled substance was already a finished product before the defendant handled it.
Relevant questions include whether the substance's effects or method of administration actually changed, whether the additional material served only as a carrier, and whether objective evidence supports the prosecution's characterization of the conduct as manufacturing.The defendant's personal-use purpose may also be relevant.
However, personal use alone does not exclude manufacturing liability. The entire process must be evaluated under the applicable legal standard.
2. Challenge Unsupported Conclusions About Drug Optimization
The expression "drug optimization processing" describes a judicial characterization of the conduct; it is not a separate statutory offense.
A defense lawyer may examine whether the conclusion that processing improved usability or increased potential harm is adequately supported by scientific and other objective evidence.
Relevant issues include whether laboratory results establish a meaningful change in concentration or properties, whether the court relies primarily on subjective descriptions, and whether the evidence sufficiently connects the alleged changes to the legal definition of manufacturing.
The purpose is not to dispute scientific facts without justification, but to ensure that the criminal classification rests on evidence rather than assumptions.
3. Examine Whether the Defendant Had the Required Manufacturing Intent
Criminal intent is another important issue.
Where the evidence suggests that the defendant intended only to prepare an already usable substance for personal consumption, the defense may argue that the conduct did not involve the legally required intent to manufacture.
However, the absence of commercial intent is not conclusive.Manufacturing for personal use may still constitute an offense if the relevant statutory elements are satisfied.
Personal-use evidence may therefore be relevant both to criminal liability and, separately, to sentencing.
4. Review Laboratory Testing, Seizure Records, and Evidence Handling
Drug manufacturing charges require reliable proof of the controlled substance and the conduct attributed to the defendant.The defense may examine the identification of the substance, the representativeness of laboratory samples, the consistency of test results, and the documented handling of seized items.
Other questions include whether each cartridge was tested, whether the seized materials were under the defendant's control, and whether the evidence establishes that the defendant personally performed the alleged processing.
Procedural defects or evidentiary gaps may affect the prosecution's ability to prove the charged offense.
5. Consider Attempted Manufacturing or a Lesser Offense
Where the evidence does not establish completed manufacturing, the defense may examine whether the alleged conduct constitutes an attempt or fails to meet the manufacturing elements altogether.
➠ If manufacturing cannot be proven, the facts may support consideration of a different offense, such as possession.
Under Article 11 of the Narcotics Hazard Prevention Act, ordinary possession of a Category 2 narcotic carries a substantially lower statutory penalty than manufacturing, subject to the applicable quantity provisions.
However, a lesser charge is not automatic merely because the quantity is small or the substance was intended for personal use.Any alternative legal characterization must be supported by the indictment facts and evidence.
6. Seek Statutory Mitigation and an Appropriate Sentence
➠ If criminal liability is established, sentencing becomes a separate and important area of defense.
Relevant circumstances may include the quantity involved, the defendant's actual role, the absence of commercial distribution, prior criminal history, rehabilitation efforts, and the extent of any demonstrated harm.
Counsel should also assess whether the requirements for confession-based mitigation under Article 17, Paragraph 2, or discretionary mitigation under Criminal Code Article 59 are satisfied.
Article 17, Paragraph 1 may provide another mitigation mechanism where the defendant identifies a drug source and the information actually leads to the apprehension of another principal offender or accomplice.
Simply naming another person or providing unverified information does not automatically satisfy this requirement.Any cooperation must be truthful and evaluated against the statutory conditions.
6. Can a Two-Year-and-Eight-Month Sentence Be Converted into a Fine?
1. Requirements for Commutation to a Fine
Under Article 41 of Taiwan's Criminal Code, commutation of imprisonment to a fine generally requires that the offense meet the applicable statutory maximum-penalty condition and that the actual sentence be no more than six months of imprisonment or short-term imprisonment.
The reported sentence of two years and eight months exceeds that threshold.Accordingly, it cannot be converted into a fine under the ordinary commutation provisions.
The severe statutory maximum for Category 2 drug manufacturing also prevents the offense from qualifying under the general five-year maximum-penalty requirement.
2. Is Community Service an Alternative?
Community service in lieu of imprisonment is a separate legal mechanism with its own statutory requirements.A sentence of two years and eight months does not fall within the ordinary short-sentence framework discussed under Article 41.
Even if a conviction were changed to a lesser offense, eligibility for commutation or community service would still depend on the final sentence and applicable statutory requirements.
The possibility of a reduced sentence should not be confused with an automatic right to avoid imprisonment.
7. What This Judgment Means for Future Drug Cases
1. Drug Manufacturing May Involve Physical Processing
The Taichung judgment illustrates that drug manufacturing allegations are not limited to laboratories or sophisticated chemical production.
Depending on the circumstances, processing an existing controlled substance may raise manufacturing issues where the conduct changes its properties, effects, or method of use.This principle may be relevant to cases involving drug-containing vape liquids, cartridges, beverage products, or other preparations.
However, the legal classification must still depend on the actual conduct and evidence.
2. Courts Must Distinguish Repackaging from Substantive Processing
The case should not be interpreted as establishing that every addition of glycerin, every dilution, or every transfer into a new container automatically constitutes drug manufacturing.
➠ A proper assessment requires consideration of the defendant's intent, the characteristics of the substance before and after processing, the laboratory findings, and the overall circumstances.
The prosecution must establish the charged offense rather than rely solely on the appearance of the finished product.
3. Drug Classification Must Be Assessed at the Correct Time
The change in etomidate's classification creates an additional issue for investigations and trials.
➠ Conduct occurring before June 27, 2026, must be analyzed in light of the law applicable at the relevant time and the rules governing changes in criminal law.Failing to distinguish the date of the alleged offense from the date of judgment may lead to an incorrect assessment of criminal penalties.
8. Legal Assistance from Chien Sheng International Law Firm
1. Criminal Defense for Drug Manufacturing and Possession Cases
Chien Sheng International Law Firm handles criminal matters involving controlled substances, including drug manufacturing, transportation, possession, distribution, and related investigations.The firm also assists with cases involving searches and seizures, laboratory testing, police questioning, prosecutorial investigations, and Investigation Bureau procedures.
Related experience includes cross-border drug transportation, drug manufacturing operations in Taiwan, fraud investigations, illegal fundraising, and Banking Act cases.
2. Building a Defense Based on the Complete Case Record
In an etomidate case, legal representation may involve reviewing the indictment, laboratory reports, seized evidence, interrogation records, and the defendant's actual conduct.
➠ The defense should distinguish the elements of manufacturing from those of possession or repackaging, identify procedural and evidentiary issues, and evaluate any available statutory sentence reductions.
A sound defense strategy should also account for the classification of the substance at the time of the alleged offense.
➠ The appropriate legal approach depends on the facts and evidence of each case. No lawyer can guarantee acquittal, non-prosecution, or a particular sentence without examining the case record.
9. Frequently Asked Questions About Etomidate Drug Manufacturing in Taiwan
Q1: Is mixing glycerin with etomidate vape oil always considered drug manufacturing in Taiwan?
No. The legal assessment depends on whether the conduct meets the elements of manufacturing. Courts must distinguish simple repackaging or possession from processing that changes the drug's characteristics, effects, or method of use.
Q2: Why was the defendant convicted of manufacturing a Category 2 narcotic when etomidate is now Category 1?
The alleged conduct occurred on October 8, 2025, when etomidate was classified as Category 2. Its reclassification to Category 1 took effect on June 27, 2026. A later, more severe classification cannot simply be applied retroactively.
Q3: Why was the defendant sentenced to only two years and eight months?
According to media reports, the court applied statutory mitigation for the defendant's admissions and further reduced the sentence under Criminal Code Article 59 after considering the limited quantity and absence of market distribution.
Q4: Does personal use prevent a drug manufacturing conviction?
Not necessarily. Manufacturing can be punishable even without an intention to sell. Personal use may be relevant to the defendant's intent, the characterization of the conduct, and sentencing, but it does not automatically exclude liability.
Q5: Can drug manufacturing charges be reduced to possession charges?
Potentially, if the evidence does not establish the required elements of manufacturing and instead supports a different offense. The outcome depends on the specific conduct, laboratory evidence, and applicable law.
Q6: Can a two-year-and-eight-month prison sentence be converted into a fine?
Not under the ordinary commutation rules in Article 41 of Taiwan's Criminal Code. The reported sentence exceeds the relevant six-month threshold, and Category 2 drug manufacturing carries a statutory maximum above the general qualifying limit.
Q7: Does confessing automatically result in a reduced sentence?
No. Sentence reduction under Article 17, Paragraph 2 of the Narcotics Hazard Prevention Act requires satisfaction of specific statutory conditions. Courts must examine the defendant's statements during investigation and successive trial proceedings.
Conclusion: Drug Manufacturing Charges Require More Than a Simple Description of Mixing or Dilution
The Taichung etomidate case demonstrates that Taiwanese drug manufacturing law may apply to certain forms of physical processing, even where no new controlled substance is chemically synthesized.
Nevertheless, the distinction between manufacturing, possession, and repackaging remains legally significant.A criminal court must examine what the defendant actually did, whether the process materially changed the substance's characteristics or method of use, whether the required criminal intent existed, and whether the prosecution's evidence is sufficient.
➡︎ The timing of the alleged conduct is equally important because etomidate's classification changed from Category 2 to Category 1 in June 2026.Individuals facing similar allegations should obtain legal advice before making detailed statements and should preserve all relevant records rather than altering or destroying evidence.
Chien Sheng International Law Firm can assist with reviewing drug identification reports, search and seizure procedures, interrogation records, the applicable narcotics classification, and potential defense or sentencing strategies.※ Legal Disclaimer: This article provides general legal information based on publicly reported case facts. The reported judgment was subject to appeal, and the final outcome must be confirmed through official court records. Actual criminal liability depends on the applicable law, evidence, and circumstances of each case.
This reduces both medical risks and potential legal exposure.
Chien Sheng International Law Firm
LINE Online Legal Consultation: @lawuicc001 (Click to consult)
Welcome to call to schedule a meeting: 03-3150-034
Multiple payment methods available: Cash, Credit Card, Bank Transfer
Facebook: Chien Sheng International Law Firm
Instagram: chien.sheng_
-
商品Q&A
